Canada Life’s Atara Biotherapeutics ATRA Stock Holding History

Canada Life’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-131	Closed	-$9K	–	2266
2023 Q1	$9K	Hold	131	–	–	﹤0.01%	2297
2022 Q4	$11K	Hold	131	–	–	﹤0.01%	2318
2022 Q3	$12K	Hold	131	–	–	﹤0.01%	2320
2022 Q2	$26K	Hold	131	–	–	﹤0.01%	2210
2022 Q1	$32K	Hold	131	–	–	﹤0.01%	2263
2021 Q4	$51K	Hold	131	–	–	﹤0.01%	2163
2021 Q3	$59K	Hold	131	–	–	﹤0.01%	2188
2021 Q2	$51K	Sell	131 -69	-35%	-$24.6K	﹤0.01%	2263
2021 Q1	$71K	Hold	200	–	–	﹤0.01%	2184
2020 Q4	$98K	Buy	200 +82	+69%	+$37.9K	﹤0.01%	2111
2020 Q3	$38K	Hold	118	–	–	﹤0.01%	2247
2020 Q2	$43K	Sell	118 -98	-45%	-$24.8K	﹤0.01%	2259
2020 Q1	$46K	Hold	216	–	–	﹤0.01%	2152
2019 Q4	$88K	Buy	+216	New	+$74.5K	﹤0.01%	2098
2019 Q3	–	Sell	-191	Closed	-$95K	–	1209
2019 Q2	$95K	Buy	+191	New	+$135K	﹤0.01%	2244
2019 Q1	–	Sell	-132	Closed	-$111K	–	2628
2018 Q4	$111K	Hold	132	–	–	﹤0.01%	2111
2018 Q3	$137K	Hold	132	–	–	﹤0.01%	2097
2018 Q2	$121K	Buy	132 +66	+100%	+$70.9K	﹤0.01%	2131
2018 Q1	$65K	Hold	66	–	–	﹤0.01%	2299
2017 Q4	$30K	Hold	66	–	–	﹤0.01%	2449
2017 Q3	$27K	Hold	66	–	–	﹤0.01%	2457
2017 Q2	$23K	Hold	66	–	–	﹤0.01%	2478
2017 Q1	$34K	Hold	66	–	–	﹤0.01%	2386
2016 Q4	$24K	Hold	66	–	–	﹤0.01%	2468
2016 Q3	$35K	Hold	66	–	–	﹤0.01%	2397
2016 Q2	$37K	Hold	66	–	–	﹤0.01%	2375
2016 Q1	$31K	Hold	66	–	–	﹤0.01%	2274
2015 Q4	$44K	Hold	66	–	–	﹤0.01%	2190
2015 Q3	$52K	Buy	+66	New	+$80.5K	﹤0.01%	2067

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Life's ATRA Position: Q2 2023 in Review

Canada Life sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 131 shares — an estimated $9K sold.

Canada Life first reported a position in ATRA in Q3 2015 and held it in 29 quarters. The position peaked at $137K in Q3 2018. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

Canada Life reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
Canada Life sold 131 Atara Biotherapeutics shares in Q2 2023, an estimated $9K.
Canada Life first reported a position in Atara Biotherapeutics in Q3 2015 and held it in 29 quarters.
Canada Life's Atara Biotherapeutics position peaked at $137K in Q3 2018.
118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.